Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It … Read more
Ekso Bionics Holdings Inc (EKSO) - Total Assets
Latest total assets as of December 2025: $20.11 Million USD
Based on the latest financial reports, Ekso Bionics Holdings Inc (EKSO) holds total assets worth $20.11 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ekso Bionics Holdings Inc - Total Assets Trend (2011–2025)
This chart illustrates how Ekso Bionics Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ekso Bionics Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Ekso Bionics Holdings Inc's total assets of $20.11 Million consist of 69.9% current assets and 30.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.8% |
| Accounts Receivable | $7.31 Million | 36.3% |
| Inventory | $4.82 Million | 24.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.50 Million | 17.4% |
| Goodwill | $431.00K | 2.1% |
Asset Composition Trend (2011–2025)
This chart illustrates how Ekso Bionics Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ekso Bionics Holdings Inc's current assets represent 69.9% of total assets in 2025, a decrease from 100.0% in 2011.
- Cash Position: Cash and equivalents constituted 5.8% of total assets in 2025, down from 100.0% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 36.3% of total assets.
Ekso Bionics Holdings Inc Competitors by Total Assets
Key competitors of Ekso Bionics Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Ekso Bionics Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Ekso Bionics Holdings Inc generates 0.64x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Ekso Bionics Holdings Inc is currently not profitable relative to its asset base.
Ekso Bionics Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.63 | 2.50 | 9.13 |
| Quick Ratio | 1.07 | 1.89 | 8.77 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.41 Million | $ 11.31 Million | $ 48.62 Million |
Ekso Bionics Holdings Inc - Advanced Valuation Insights
This section examines the relationship between Ekso Bionics Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.49 |
| Latest Market Cap to Assets Ratio | 1.42 |
| Asset Growth Rate (YoY) | -24.5% |
| Total Assets | $20.11 Million |
| Market Capitalization | $28.47 Million USD |
Valuation Analysis
Above Book Valuation: The market values Ekso Bionics Holdings Inc's assets above their book value (1.42 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Ekso Bionics Holdings Inc's assets decreased by 24.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Ekso Bionics Holdings Inc (2011–2025)
The table below shows the annual total assets of Ekso Bionics Holdings Inc from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $20.11 Million | -24.54% |
| 2024-12-31 | $26.65 Million | -7.84% |
| 2023-12-31 | $28.92 Million | -29.30% |
| 2022-12-31 | $40.90 Million | -16.81% |
| 2021-12-31 | $49.17 Million | +138.70% |
| 2020-12-31 | $20.60 Million | -6.01% |
| 2019-12-31 | $21.91 Million | +24.13% |
| 2018-12-31 | $17.66 Million | -53.52% |
| 2017-12-31 | $37.99 Million | +55.53% |
| 2016-12-31 | $24.43 Million | -24.14% |
| 2015-12-31 | $32.20 Million | -3.81% |
| 2014-12-31 | $33.47 Million | +114635.22% |
| 2013-12-31 | $29.18K | 0.00% |
| 2012-12-31 | $29.18K | +245.55% |
| 2011-12-31 | $8.44K | -- |